PRINCETON, NJ – June 6, 2017 – Certara today launched its Clinical Outcomes Database Explorer (CODEx). An intuitive, web-based platform, CODEx enables drug development teams to easily visualize, explore, analyze and communicate content from Certara’s Clinical Trial Outcomes Databases and assess a given compound’s probability of success against competitor drugs.
PRINCETON, NJ – June 5, 2017 – Certara today announced that its scientists are playing leading roles in more than 30 sessions at the Population Approach Group in Europe (PAGE) 2017 Annual Meeting. PAGE is a UK-based, nonprofit organization, which is committed to taking a population approach to data analysis. This year’s meeting is being held in Budapest, Hungary from June 6-9.
PRINCETON, NJ – May 31, 2017 – Certara today announced that it is partnering with Phase I Unit, Peking Union Medical College (PUMC) Hospital’s Clinical Pharmacology Research Center (PUMCH-CPRC) in Beijing to help Chinese pharmaceutical companies enhance their drug development processes.
PRINCETON, NJ – May 15, 2017 – Certara today announced that it has appointed Sandy Allerheiligen, PhD, to the newly-created role of Senior Vice President of Health Economics and Education.
PRINCETON, NJ – Apr. 19, 2017 – Certara today announced the launch of a new solution for preparing, analyzing and submitting PK data in Clinical Data Exchange Standards Consortium (CDISC) format. CDISC supports the acquisition, exchange, submission and archiving of non-clinical and clinical data.
PRINCETON, NJ – Apr. 5. 2017 – Certara today announced that its d3 Medicine company has been selected to conduct a national audit of Australia’s medical countermeasures (MCM) product research and development (R&D) capabilities and capacity.
PRINCETON, NJ – Mar. 13, 2017 – Certara today announced that its scientists will be highlighting pharmacokinetic (PK) and pharmacodynamic (PD) modeling advances during 19 sessions at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2017 Annual Meeting.
PRINCETON, NJ – Mar. 9, 2017 – Certara today announced the launch of Simcyp Access, a new cloud-based licensing approach that provides trained individuals at smaller pharmaceutical companies (less than 500 employees) with a method for using Certara’s Simcyp Population-based Simulator in research projects.
PRINCETON, NJ – Feb. 22, 2017 – Certara today announced that the Standards Council of Canada (SCC) has awarded Good Laboratory Practices (GLP) certification to its Certara Strategic Consulting (CSC) Montreal facility.
PRINCETON, NJ – Feb. 15, 2017 – Certara today announced that Professor Piet van der Graaf, PharmD, PhD, its vice president of quantitative systems pharmacology, has been appointed a F1000Prime faculty member.